Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CytomX Therapeutics Inc (DE:6C1)
FRANKFURT:6C1
Holding DE:6C1?
Track your performance easily
CytomX Therapeutics (6C1) Ownership Overview
1.69% Insiders
7.89% Mutual Funds
35.89% Other Institutional Investors
5.41% ETFs
49.12% Public Companies and
Individual Investors
The ownership structure of CytomX Therapeutics (DE:6C1) stock is a mix of institutional, retail, and individual investors. Approximately 49.19% of the company’s stock is owned by Institutional Investors, 1.69% is owned by Insiders, and 49.12% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 21, 2024 | Sean A. Mccarthy Ceo,director | xxxxxxxxxxxxx | $42064 |
| Mar 21, 2024 | xxxxxxxxxxxxx | $13649 | |
| Mar 21, 2024 | xxxxxxxxxxxxx | $10957 | |
| Mar 21, 2024 | xxxxxxxxxxxxx | $6180 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $464721 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,436,953 | Institution | 4.39% | 3,705,035 | |
| 3,436,953 | Institution | 4.39% | 3,705,035 | |
| 820,461 | Institution | 1.05% | 884,457 | |
| 751,009 | Insider | 0.96% | 809,588 | |
| 668,155 | Institution | 0.85% | 720,271 | |
| 555,119 | Institution | 0.71% | 598,418 | |
| 393,832 | Institution | 0.50% | 424,551 | |
| 382,529 | Institution | 0.49% | 412,366 | |
| 356,624 | Institution | 0.46% | 384,441 | |
| 194,258 | Institution | 0.25% | 209,410 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,436,953 | Institution | 4.39% | 3,705,035 | |
| 820,461 | Institution | 1.05% | 884,457 | |
| 668,155 | Institution | 0.85% | 720,271 | |
| 555,119 | Institution | 0.71% | 598,418 | |
| 356,624 | Institution | 0.46% | 384,441 | |
| 106,678 | Institution | 0.14% | 114,999 | |
| 46,356 | Institution | 0.06% | 49,972 | |
| 46,219 | Institution | 0.06% | 49,824 | |
| 44,926 | Institution | 0.06% | 48,430 | |
| 41,458 | Institution | 0.05% | 44,692 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns CytomX Therapeutics Inc (DE:6C1)?
According to the latest TipRanks data, approximately 35.89% of the company's stock is held by institutional investors, 1.69% is held by insiders, and 49.12% is held by retail investors.
What percentage of CytomX Therapeutics Inc (DE:6C1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.89% of CytomX Therapeutics Inc (DE:6C1) stock is held by institutional investors.
What percentage of CytomX Therapeutics Inc (DE:6C1) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.12% of CytomX Therapeutics Inc (DE:6C1) stock is held by retail investors.
Who owns the most shares of CytomX Therapeutics Inc (DE:6C1)?
Vanguard owns the most shares of CytomX Therapeutics Inc (DE:6C1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.